JP2013506639A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013506639A5 JP2013506639A5 JP2012531448A JP2012531448A JP2013506639A5 JP 2013506639 A5 JP2013506639 A5 JP 2013506639A5 JP 2012531448 A JP2012531448 A JP 2012531448A JP 2012531448 A JP2012531448 A JP 2012531448A JP 2013506639 A5 JP2013506639 A5 JP 2013506639A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- compound
- formula
- halo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 *C(C(C1=NC(*)=C(*)*1)=O)(I)I Chemical compound *C(C(C1=NC(*)=C(*)*1)=O)(I)I 0.000 description 20
- PQJGNSFZEGGFDP-UHFFFAOYSA-N CC(C)CC(C1SC(CCC=C2)=C2N1)=O Chemical compound CC(C)CC(C1SC(CCC=C2)=C2N1)=O PQJGNSFZEGGFDP-UHFFFAOYSA-N 0.000 description 1
- IHSWAXVALJQQHH-UHFFFAOYSA-N CC1SC(C(CCCCc2ccccc2)=O)=NC1CC(O)=O Chemical compound CC1SC(C(CCCCc2ccccc2)=O)=NC1CC(O)=O IHSWAXVALJQQHH-UHFFFAOYSA-N 0.000 description 1
- KKAIZYXTTAZXFM-DOFZRALJSA-N CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(c1ncc[s]1)=O Chemical compound CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(c1ncc[s]1)=O KKAIZYXTTAZXFM-DOFZRALJSA-N 0.000 description 1
- FJFVPRCVGZYKLW-UHFFFAOYSA-N CCCCCCCCc1ccc(CCCCC(c2nc(CC(OCC)=O)c[s]2)=O)cc1 Chemical compound CCCCCCCCc1ccc(CCCCC(c2nc(CC(OCC)=O)c[s]2)=O)cc1 FJFVPRCVGZYKLW-UHFFFAOYSA-N 0.000 description 1
- ZZEVFTHVFLUSMQ-UHFFFAOYSA-N CCCCCCOc1ccc(CCC(c2ncc[s]2)=O)cc1 Chemical compound CCCCCCOc1ccc(CCC(c2ncc[s]2)=O)cc1 ZZEVFTHVFLUSMQ-UHFFFAOYSA-N 0.000 description 1
- RYSJFVJZNUIROH-UHFFFAOYSA-N CCOC(CC1N=C(C(CCCCc2ccccc2)=O)SC1C)=O Chemical compound CCOC(CC1N=C(C(CCCCc2ccccc2)=O)SC1C)=O RYSJFVJZNUIROH-UHFFFAOYSA-N 0.000 description 1
- TXDCWKNQQRDWSA-UHFFFAOYSA-N CCOC(Cc1c[s]c(C(CCCCc(cc2)ccc2-c2ccccc2)=O)n1)=O Chemical compound CCOC(Cc1c[s]c(C(CCCCc(cc2)ccc2-c2ccccc2)=O)n1)=O TXDCWKNQQRDWSA-UHFFFAOYSA-N 0.000 description 1
- RLSFQYHAXBLCBR-UHFFFAOYSA-N CNC(c1nc(/[O]=C(\CCCCc2ccccc2)/c2ncc[s]2)c[s]1)=O Chemical compound CNC(c1nc(/[O]=C(\CCCCc2ccccc2)/c2ncc[s]2)c[s]1)=O RLSFQYHAXBLCBR-UHFFFAOYSA-N 0.000 description 1
- RKGDIPCRLQAWTF-UHFFFAOYSA-N COC(c1c[s]c(C(CCCCc(cc2)ccc2-c2ccccc2)=O)n1)=O Chemical compound COC(c1c[s]c(C(CCCCc(cc2)ccc2-c2ccccc2)=O)n1)=O RKGDIPCRLQAWTF-UHFFFAOYSA-N 0.000 description 1
- PKRTXQVTIJMLGE-UHFFFAOYSA-N O=C(CCCCc1cc(cccc2)c2cc1)c1nc(cccc2)c2[s]1 Chemical compound O=C(CCCCc1cc(cccc2)c2cc1)c1nc(cccc2)c2[s]1 PKRTXQVTIJMLGE-UHFFFAOYSA-N 0.000 description 1
- KTIZWGOVAMQNDW-UHFFFAOYSA-N O=C(CCCCc1ccccc1)c1nc(cccc2)c2[s]1 Chemical compound O=C(CCCCc1ccccc1)c1nc(cccc2)c2[s]1 KTIZWGOVAMQNDW-UHFFFAOYSA-N 0.000 description 1
- NDCYLDBUFWAIPG-UHFFFAOYSA-N O=C(CNC(Cc1ccccc1)=O)c1nc(cccc2)c2[s]1 Chemical compound O=C(CNC(Cc1ccccc1)=O)c1nc(cccc2)c2[s]1 NDCYLDBUFWAIPG-UHFFFAOYSA-N 0.000 description 1
- AVANAVVVGAMZMA-UHFFFAOYSA-N OC(C1N=C(C(CCCCc2ccccc2)=O)SC1)=O Chemical compound OC(C1N=C(C(CCCCc2ccccc2)=O)SC1)=O AVANAVVVGAMZMA-UHFFFAOYSA-N 0.000 description 1
- IHRLCNBSCIRRMD-UHFFFAOYSA-N OC(c1c[s]c(C(CCCCc(cc2)ccc2-c2ccccc2)=O)n1)=O Chemical compound OC(c1c[s]c(C(CCCCc(cc2)ccc2-c2ccccc2)=O)n1)=O IHRLCNBSCIRRMD-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24833809P | 2009-10-02 | 2009-10-02 | |
| US61/248,338 | 2009-10-02 | ||
| PCT/EP2010/064687 WO2011039365A1 (en) | 2009-10-02 | 2010-10-01 | Anti inflammatory 2-oxothiazoles and 2 -oxooxazoles |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013506639A JP2013506639A (ja) | 2013-02-28 |
| JP2013506639A5 true JP2013506639A5 (enExample) | 2013-08-15 |
| JP6012468B2 JP6012468B2 (ja) | 2016-10-25 |
Family
ID=43221889
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012531448A Expired - Fee Related JP6012468B2 (ja) | 2009-10-02 | 2010-10-01 | 抗炎症性２−オキソチアゾールおよび２−オキソオキサゾール |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US9597318B2 (enExample) |
| EP (2) | EP3431084A1 (enExample) |
| JP (1) | JP6012468B2 (enExample) |
| KR (4) | KR20190082985A (enExample) |
| CN (3) | CN103772312B (enExample) |
| AU (1) | AU2010302584B2 (enExample) |
| CA (1) | CA2782797C (enExample) |
| DK (1) | DK2482815T3 (enExample) |
| IN (1) | IN2012DN02982A (enExample) |
| NO (1) | NO2482815T3 (enExample) |
| WO (1) | WO2011039365A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20190082985A (ko) | 2009-10-02 | 2019-07-10 | 아벡신 에이에스 | 소염제 2-옥소티아졸 및 2-옥소옥사졸 |
| GB201205394D0 (en) | 2012-03-27 | 2012-05-09 | Adlens Ltd | Improvements in or relating to deformable non-round membrane assemblies |
| GB201221329D0 (en) * | 2012-11-27 | 2013-01-09 | Avexxin As | Dermatitis treatment |
| AU2014211489A1 (en) * | 2013-01-29 | 2015-08-13 | Avexxin As | Antiinflammatory and antitumor 2-oxothiazoles and 2-oxothiophenes compounds |
| GB201307331D0 (en) * | 2013-04-23 | 2013-05-29 | Norwegian Univ Sci & Tech Ntnu | Compound |
| GB201409363D0 (en) | 2014-05-27 | 2014-07-09 | Avexxin As | Skin cancer treatment |
| GB201413695D0 (en) | 2014-08-01 | 2014-09-17 | Avexxin As | Compound |
| GB201604318D0 (en) | 2016-03-14 | 2016-04-27 | Avexxin As | Combination therapy |
| GB201604316D0 (en) | 2016-03-14 | 2016-04-27 | Avexxin As | Combination therapy |
| GB2550363A (en) * | 2016-05-16 | 2017-11-22 | Avexxin As | Compound |
| WO2018055062A1 (en) | 2016-09-21 | 2018-03-29 | Avexxin As | Pharmaceutical composition |
| CA3042589A1 (en) * | 2016-11-04 | 2018-05-11 | Avexxin As | Combination therapy comprising a thiazole and a corticosteroid to treat skin conditions |
| WO2018083227A1 (en) * | 2016-11-04 | 2018-05-11 | Avexxin As | Combination therapy comprising a thiazole and a secosteroid to treat skin conditions |
| JP7169584B2 (ja) * | 2018-01-30 | 2022-11-11 | 公立大学法人横浜市立大学 | オーキシン生合成阻害活性を有する新規化合物、その製造方法及びその用途 |
| GB201806663D0 (en) | 2018-04-24 | 2018-06-06 | Avexxin As | 2-Oxothiazole compositions for treatment of fibrotic disease |
| EP3677259A1 (en) * | 2019-01-07 | 2020-07-08 | Mosaiques Diagnostics And Therapeutics AG | Use of arachidonyl trifluoromethyl ketone |
| GB202117609D0 (en) | 2021-12-06 | 2022-01-19 | Coegin Pharma Ab | 2-Oxothiazole compositions for treatment of T-cell acute lymphoblastic leukaemia |
| CN115028597B (zh) * | 2022-04-29 | 2024-03-26 | 闽都创新实验室 | 一种tempo连续脱氢环化制备苯并恶唑类衍生物的方法和应用 |
| WO2025125241A1 (en) | 2023-12-15 | 2025-06-19 | Coegin Pharma Ab | Pharmaceutical composition |
Family Cites Families (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3894152A (en) * | 1969-09-15 | 1975-07-08 | Innothera Lab Sa | Use of (thienyl-3)(3-N-morpholine-propy)ketone |
| FR2062868B1 (enExample) * | 1969-09-15 | 1973-08-10 | Innothera Lab Sa | |
| DE2063901A1 (en) | 1970-12-28 | 1972-07-20 | Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt | Phenylalkylaminoalkylthiazoles - as antiphlogistics |
| PH22520A (en) | 1984-11-12 | 1988-10-17 | Yamanouchi Pharma Co Ltd | Heterocyclic compounds having 4-lover alkyl-3-hydroxy-2-lower alkyl phenoxy-lower alkylene-y-group, and process of producing them |
| US5177215A (en) | 1984-11-12 | 1993-01-05 | Yamanouchi Pharmaceutical Co., Ltd. | Heterocyclic compounds and pharmaceutical use thereof |
| JPS62142168A (ja) | 1985-10-16 | 1987-06-25 | Mitsubishi Chem Ind Ltd | チアゾ−ル誘導体及びそれを有効成分とするロイコトリエンきつ抗剤 |
| ZA894913B (en) | 1988-07-12 | 1990-03-28 | Ici Pharma | Heterocyclic compounds |
| US5272986A (en) | 1991-05-13 | 1993-12-28 | British Gas Plc | Towing swivel for pipe inspection or other vehicle |
| TW263504B (enExample) | 1991-10-03 | 1995-11-21 | Pfizer | |
| GB9211706D0 (en) | 1992-06-03 | 1992-07-15 | Celltech Ltd | Peptidyl derivatives |
| US5273986A (en) | 1992-07-02 | 1993-12-28 | Hoffmann-La Roche Inc. | Cycloalkylthiazoles |
| US5268395A (en) | 1992-10-13 | 1993-12-07 | Martin Marietta Energy Systems, Inc. | Microcellular carbon foam and method |
| JP3345476B2 (ja) * | 1993-05-18 | 2002-11-18 | 株式会社東芝 | 有機非線形光学材料 |
| US5569655A (en) * | 1993-09-14 | 1996-10-29 | Sterling Winthrop Inc. | Substituted heterocyclylisoquinolinium salts and compositions and method of use thereof |
| JPH10504542A (ja) | 1994-07-27 | 1998-05-06 | ジー．ディー．サール アンド カンパニー | 炎症処置用の置換チアゾール化合物 |
| US5658909A (en) * | 1994-11-17 | 1997-08-19 | Molecular Geriatrics Corporation | Certain substituted 1-aryl-3-piperazin-1'-yl propanones to treat Alzheimer's Disease |
| US5693804A (en) * | 1994-11-17 | 1997-12-02 | Molecular Geriatrics Corporation | Substituted 1-aryl-3-piperazin-1'-yl propanones |
| US6214994B1 (en) * | 1997-04-21 | 2001-04-10 | Molecular Geriatrics Corporation | Certain substituted 1-aryl-3-piperazin-1′-yl propanones |
| TW438786B (en) | 1995-03-28 | 2001-06-07 | Nippon Zoki Pharmaceutical Co | Novel benzothiazole derivatives |
| EP0825989A1 (en) * | 1995-05-19 | 1998-03-04 | G.D. Searle & Co. | Substituted oxazoles for the treatment of inflammation |
| CA2224121A1 (en) * | 1995-06-06 | 1996-12-12 | Donna Kaye Wilson | Stereoselective method for synthesizing dolaphenine |
| DE19638408A1 (de) * | 1996-09-19 | 1998-03-26 | Merckle Gmbh | 1-Substituierte 3-Acyl-4,5-dimethylpyrrol-2-carbonsäuren und 3-Acylindol-2-carbonsäuren sowie ihre Derivate als Hemmstoffe der cytosolischen Phospholipase A¶2¶ |
| EP0975603A1 (en) * | 1997-01-29 | 2000-02-02 | Zeneca Limited | Inhibitors of farnesyl protein transferase |
| EP0867437B1 (en) | 1997-03-14 | 2002-11-13 | Koninklijke Philips Electronics N.V. | "Method of preparing a thiophene-containing or furan -containing conjugated compound and precursor compound used therein". |
| AU730364B2 (en) * | 1997-09-23 | 2001-03-08 | Bristol-Myers Squibb Company | Selective cPLA2 inhibitors |
| JPH11255700A (ja) | 1998-03-12 | 1999-09-21 | Taiho Ind Co Ltd | アセチルアセトン系金属錯体及びその合成法、並びにそれを用いた有機多層型エレクトロルミネッセンス素子 |
| WO2000009500A2 (en) | 1998-08-11 | 2000-02-24 | Nihon Bayer Agrochem K.K. | Nematicidal pyrazoles |
| SE9804212D0 (sv) * | 1998-12-04 | 1998-12-04 | Astra Pharma Prod | Compounds |
| WO2001000578A1 (en) | 1999-06-25 | 2001-01-04 | Merck & Co., Inc. | 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof |
| JP2001240593A (ja) * | 1999-10-12 | 2001-09-04 | Japan Tobacco Inc | 高トリグリセリド血症治療薬及び抗肥満薬 |
| US6462054B1 (en) * | 2000-03-27 | 2002-10-08 | The Scripps Research Institute | Inhibitors of fatty acid amide hydrolase |
| AU5878001A (en) | 2000-05-18 | 2001-11-26 | Daiichi Pharmaceutical Co., Ltd. | Novel benzothiophene derivatives |
| US20020052373A1 (en) | 2000-10-26 | 2002-05-02 | Zorn Stevin H. | Combination treatment for dementia or cognitive deficits associated with alzheimer's disease and parkinson's disease |
| US6734207B2 (en) * | 2001-04-20 | 2004-05-11 | Parker Hughes Institute | Cytotoxic compounds |
| US7056917B2 (en) | 2001-04-26 | 2006-06-06 | Daiichi Pharmaceutical Co., Ltd. | Drug efflux pump inhibitor |
| WO2003051194A1 (en) | 2001-12-18 | 2003-06-26 | 3Cpm Company | Endoscopic measurement of myoelectrical activity from intra-abdominal organs |
| GB0202002D0 (en) * | 2002-01-29 | 2002-03-13 | Leiv Eiriksson Nyotek A S | Use |
| WO2004011410A1 (en) * | 2002-07-27 | 2004-02-05 | Astrazeneca Ab | Chemical compounds |
| SE0202463D0 (sv) | 2002-08-14 | 2002-08-14 | Astrazeneca Ab | Novel compounds |
| US6930391B2 (en) | 2002-08-27 | 2005-08-16 | Intel Corporation | Method for alloy-electroplating group IB metals with refractory metals for interconnections |
| AU2003275493A1 (en) * | 2002-10-08 | 2004-05-04 | The Scripps Research Institute | Inhibitors of fatty acid amide hydrolase |
| GB2394894B (en) | 2002-11-04 | 2005-08-31 | G W Pharma Ltd | New use for pharmaceutical composition |
| AU2003276458A1 (en) | 2002-11-07 | 2004-06-07 | Astrazeneca Ab | 2-oxo-ethanesulfonamide derivates |
| EP1674460B1 (en) | 2003-09-18 | 2009-01-21 | Tokuyama Corporation | Chromene compound |
| AR045651A1 (es) * | 2003-09-19 | 2005-11-02 | Solvay Pharm Bv | Derivados de tiazol como moduladores del receptor de cannabinoide |
| JP4226438B2 (ja) | 2003-10-23 | 2009-02-18 | エヌ・ティ・ティ・コムウェア株式会社 | パック装置およびセンステーブル装置、ならびに移動軌跡算出方法、移動軌跡算出プログラム、その記録媒体 |
| US20050137243A1 (en) | 2003-12-23 | 2005-06-23 | Souers Andrew J. | Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor |
| JP2005343889A (ja) * | 2004-05-06 | 2005-12-15 | Taisho Pharmaceut Co Ltd | イミダゾピリジン誘導体 |
| AU2005243384A1 (en) | 2004-05-17 | 2005-11-24 | Otsuka Pharmaceutical Co., Ltd. | Thiazole compound and use thereof |
| US7178364B2 (en) | 2004-07-22 | 2007-02-20 | Shapiro Kristen M | Personal adornment |
| WO2006016218A1 (en) * | 2004-08-03 | 2006-02-16 | Pfizer Japan Inc. | Aryl or heteroaryl carbonyl derivatives derivatives useful as vanilloid receptor 1 (vr1) antagonists |
| KR20060058632A (ko) * | 2004-11-25 | 2006-05-30 | 주식회사 엘지생명과학 | ＰＰＡＲ ｇａｍｍａ와 ＰＰＡＲ ａｌｐｈａ의 활성을항진시키는 신규 화합물, 그것의 제조방법, 및 그것을함유한 약제 조성물 |
| WO2007061862A2 (en) * | 2005-11-18 | 2007-05-31 | Janssen Pharmaceutica N.V. | 2-keto-oxazoles as modulators of fatty acid amide hydrolase |
| DK3184526T3 (en) * | 2005-12-13 | 2019-01-14 | Incyte Holdings Corp | PYRROLO [2,3-D] PYRIMIDINE DERIVATIVES AS A JANUS-KINASE INHIBITOR |
| US7915270B2 (en) * | 2006-02-17 | 2011-03-29 | The Scripps Research Institute | Oxazole ketones as modulators of fatty acid amide hydrolase |
| EP2051964A4 (en) * | 2006-07-28 | 2012-03-07 | Univ Connecticut | INHIBITORS OF FATTY ACID AMIDHYDROLASE |
| DK2116530T3 (da) | 2007-02-26 | 2013-01-28 | Santen Pharmaceutical Co Ltd | Nyt pyrrolderivat, der har en ureidgruppe og en aminobonylgruppe som substituenter |
| BRPI0808348A2 (pt) * | 2007-03-05 | 2014-07-15 | Hoffmann La Roche | Aminoamidas como antagonistas de orexina |
| AU2008260496A1 (en) * | 2007-05-31 | 2008-12-11 | The Scripps Research Institute | Tricyclic inhibitors of fatty acid amide hydrolase |
| KR20190082985A (ko) | 2009-10-02 | 2019-07-10 | 아벡신 에이에스 | 소염제 2-옥소티아졸 및 2-옥소옥사졸 |
| CN103228641A (zh) | 2010-11-22 | 2013-07-31 | 日立化成株式会社 | 稀土类金属络合物 |
| AU2014211489A1 (en) * | 2013-01-29 | 2015-08-13 | Avexxin As | Antiinflammatory and antitumor 2-oxothiazoles and 2-oxothiophenes compounds |
| GB201413695D0 (en) * | 2014-08-01 | 2014-09-17 | Avexxin As | Compound |
-
2010
- 2010-10-01 KR KR1020197018997A patent/KR20190082985A/ko not_active Withdrawn
- 2010-10-01 CN CN201310675185.1A patent/CN103772312B/zh not_active Expired - Fee Related
- 2010-10-01 WO PCT/EP2010/064687 patent/WO2011039365A1/en not_active Ceased
- 2010-10-01 KR KR1020127011173A patent/KR20120089701A/ko not_active Ceased
- 2010-10-01 DK DK10759934.2T patent/DK2482815T3/en active
- 2010-10-01 CN CN201080056033.8A patent/CN102647984B/zh not_active Expired - Fee Related
- 2010-10-01 AU AU2010302584A patent/AU2010302584B2/en not_active Ceased
- 2010-10-01 NO NO10759934A patent/NO2482815T3/no unknown
- 2010-10-01 CN CN201510086534.5A patent/CN104892542B/zh not_active Expired - Fee Related
- 2010-10-01 IN IN2982DEN2012 patent/IN2012DN02982A/en unknown
- 2010-10-01 EP EP18170271.3A patent/EP3431084A1/en not_active Withdrawn
- 2010-10-01 CA CA2782797A patent/CA2782797C/en active Active
- 2010-10-01 JP JP2012531448A patent/JP6012468B2/ja not_active Expired - Fee Related
- 2010-10-01 KR KR1020187028820A patent/KR101997163B1/ko not_active Expired - Fee Related
- 2010-10-01 KR KR1020177008521A patent/KR101907535B1/ko not_active Expired - Fee Related
- 2010-10-01 EP EP10759934.2A patent/EP2482815B1/en not_active Not-in-force
- 2010-10-04 US US12/897,510 patent/US9597318B2/en not_active Expired - Fee Related
-
2017
- 2017-02-24 US US15/442,568 patent/US10370344B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013506639A5 (enExample) | ||
| JP2012524053A5 (enExample) | ||
| JP2012504133A5 (enExample) | ||
| HRP20180335T1 (hr) | Kondenzirani derivati imidazola korisni kao ido inhibitori | |
| JP2011057693A5 (enExample) | ||
| JP2012522759A5 (enExample) | ||
| JP2011520815A5 (enExample) | ||
| JP2017514838A5 (enExample) | ||
| JP2009530398A5 (enExample) | ||
| MY161233A (en) | Bis (fluoroalkyl)-1, 4-benzodiazepinone compounds | |
| JP2018509409A5 (enExample) | ||
| RU2012131416A (ru) | Ингибиторы фосфатидилинозитол-3-киназы на основе изоиндолинона | |
| RU2015133450A (ru) | Соединения имидазопиридина и их применение | |
| JP2014511892A5 (enExample) | ||
| RU2013123275A (ru) | Пиперидин-4-илазетидиндиамиды как ингибиторы моноацилглицеринлипазы | |
| JP2009531322A5 (enExample) | ||
| JP2019502763A5 (enExample) | ||
| EA201391629A1 (ru) | Ингибиторы цсж-1r для лечения опухолей головного мозга | |
| JP2012526148A5 (enExample) | ||
| HRP20150167T4 (hr) | Spojevi kao antagonisti bradikinina-b1 | |
| RU2018120242A (ru) | Хинолиновые соединения, способы их получения и их применения в качестве лекарственного средства, ингибирующего транспортер уратов | |
| JP2013525356A5 (enExample) | ||
| JP2020520955A5 (enExample) | ||
| EA201500050A1 (ru) | Бифтордиоксалан-амино-бензимидазольные ингибиторы киназы для лечения рака, аутоиммунного воспаления и нарушений цнс | |
| CN113365998A (zh) | 用于parp抑制剂的吲哚并七元酰肟类似物 |